procainamide

Procainamide (Novocainamide) is a specific and potent DNA methyltransferase 1 (DNMT1) inhibitor and a Class 1A antiarrhythmic agent, with potential applications in cancer and arrhythmia research [1] [2].

A3G3S3 glycan, procainamide labelled (A3G3S3 N-linked oligosaccharide, procainamide labelled), is a versatile fluorescent linker composed of N-glycoproteins. The resulting conjugates mimic the antenna structures of N-glycans, offering high sensitivity and specificity.

A2G2 glycan (G2), procainamide labelled (A2G2 N-linked oligosaccharide, procainamide labelled; A2G(4)2 glycan, procainamide labelled) is a polymeric N-glycoprotein that serves as a multifunctional fluorescent linker. The resulting conjugate, by emulating the antennae structures of N-glycans, exhibits high sensitivity and specificity.

FA2[3]G1 & FA2[6]G1 glycan (G1F), procainamide labelled, is a poly-N-glycoprotein serving as a versatile fluorescent linkage (Linker). The resulting conjugate, mimicking the antenna elements of N-glycans, exhibits high sensitivity and specificity.

M7 glycan (Man7), procainamide labelled (Mannose-7 N-linked oligosaccharide, procainamide labelled; Oligomannose 7 glycan, procainamide labelled) is a polymeric N-glycoprotein functioning as a versatile fluorescent linker. The conjugate obtained simulates the antenna elements of N-glycans, providing high sensitivity and specificity.

A4 glycan, procainamide labelled (A4 N-linked oligosaccharide, procainamide labelled), is a polymeric N-glycoprotein and serves as a multifunctional fluorescent linker. The resulting conjugate, by mimicking the antenna elements of N-glycans, offers high sensitivity and specificity.

A2 glycan (G0), procainamide labelled (A2 N-linked oligosaccharide, procainamide labelled), is a multifunctional fluorescent linker consisting of a polymeric N-glycoprotein. The resulting conjugate mimics the antenna elements of N-glycans, offering high sensitivity and specificity.

A3G3 glycan (G3), procainamide labelled (A3G3 N-linked oligosaccharide, procainamide labelled; A3G(4)3 glycan, procainamide labelled) is a polyglycosylated N-protein that serves as a versatile fluorescent linker. The resulting conjugate exhibits high sensitivity and specificity by mimicking the antennary elements of N-glycans.

M8 glycan (Man8), procainamide labelled (Mannose-8 N-linked oligosaccharide, procainamide labelled; Oligomannose 8 glycan, procainamide labelled), is a multifunctional fluorescent linker used in poly-N-glycoproteins. The conjugates formed display high sensitivity and specificity by mimicking the antennal elements of N-glycans.

M6 glycan (Man6), procainamide labelled (Mannose-6 N-linked oligosaccharide, procainamide labelled), is a multifunctional fluorescent linker that serves as a polymer of N-glycoprotein. The resulting conjugate mimics the antennal elements of N-glycans, offering high sensitivity and specificity.

FA2G2S1 glycan (G2FS1), procainamide labelled (FA2G2S1 N-linked oligosaccharide, procainamide labelled; α(2,6)/FA2G2S(6)1 glycan, procainamide labelled; F(6)A2G(4)2S(6)1 glycan, procainamide labelled), is a multifaceted fluorescent linker that serves as a poly N-glycoprotein. The resulting conjugate, which mimics the antenna structures of N-glycans, exhibits high sensitivity and specificity.

M5 glycan (Man5), procainamide labelled (Mannose-5 N-linked oligosaccharide, procainamide labelled; Oligomannose 5 glycan, procainamide labelled) is a multifunctional fluorescent linker that acts as a poly-N-glycoprotein. The resultant conjugate exhibits high sensitivity and specificity by mimicking the antenna-like elements of N-glycans.

M9 glycan (Man9), procainamide labelled (Mannose-9 N-linked oligosaccharide, procainamide labelled; Oligomannose 9 glycan, procainamide labelled) is a type of poly N-glycoprotein and serves as a versatile fluorescent linker. The resulting conjugates possess high sensitivity and specificity by mimicking the antennae elements of N-glycans.

Procainamide Hydrochloride (Procapan) is the hydrochloride salt form of procainamide, an amide derivative exhibiting class 1A antiarrhythmic property and analog of procaine. Procainamide hydrochloride reversibly binds to and blocks activated (open) voltage-gated sodium channels, thereby blocks the influx of sodium ions into the cell, which leads to an increase in threshold for excitation and inhibit depolarization during phase 0 of the action potential.

Procainamide hydrochloride (Standard) is the standard substance of Procainamide hydrochloride, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Procainamide Hydrochloride (Procapan) is the hydrochloride salt form of procainamide, an amide derivative exhibiting class 1A antiarrhythmic property and analog of procaine. Procainamide hydrochloride reversibly binds to and blocks activated (open) voltage-gated sodium channels, thereby blocks the influx of sodium ions into the cell, which leads to an increase in threshold for excitation and inhibit depolarization during phase 0 of the action potential.

N-Acetylprocainamide (NAPA), the N-acetylated metabolite of Procainamide, is a Class III antiarrhythmic agent, while procainamide is a Class Ia antiarrhythmic drug.

Procainamide-d10 is a deuterated compound of Procainamide. Procainamide has a CAS number of 51-06-9. Procainamide is a specific and potent inhibitor of DNA methyltransferase 1 (DNMT1). Procainamide is a Class 1A antiarrhythmic agent. Procainamide has the potential for the research of cancer and arrhythmias.

Declopramide (OXI-104) is a novel chemosensitizer with antitumor activity that induces apoptosis and can be used to study colorectal cancer and inflammatory bowel disease.

Metoclopramide (5-Chloro-2-methoxyprocainamide) is a dopamine D2 antagonist which has been used for treatment of a variety of gastrointestinal symptoms over the last thirty years. In various countries, metoclopramide is the antiemetic drug of choice in pregnant women. Findings provide reassurance regarding the safety of metoclopramide for the fetus when the drug is given to women to relieve nausea and vomiting during pregnancy. Evidence also supports its use for gastroparesis (poor stomach emptying) and gastroesophageal reflux disease. It appears to bind to dopamine D2 receptors where it is a receptor antagonist, and is also a mixed 5-HT3 receptor antagonist/ 5-HT4 receptor agonist.

Acecainide hydrochloride (NAPA) is the major hepatic metabolite of procainamide and its antiarrhythmic effects may lead to cardiotoxicity in renal failure.

DA 1686 is a therapeutic antiarrhythmic compound.DA 1686 reduces the tachycardic effects of aconitine. It also reduces the effects of increased frequency of electrical stimulation and is 1.8 times more active than quinidine and 9 times more active than procainamide.

CH 200 is a novel antiarrhythmic drug that inhibits arrhythmias in beagles more effectively than procainamide and lidocaine.